A phase II trial of docetaxel with bevacizumab as first line therapy for Her2/neu negative metastatic breast carcinoma. S. A. Hurvitz,F. F. Kabbinavar, H. J. Len, R. L. Moroose,D. Chan,C. Hagenstad, S. H. Applebaum, G. Patel,E. H. Hu,D. Reese,D. J. SlamonBREAST CANCER RESEARCH AND TREATMENT（2007）引用 1|浏览10暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
